Evan Gibson is a biotech executive with over 20 years of experience spanning corporate development, company formation, and investment banking. He most recently served as Chief Business Officer at Aditum Bio. Prior to Aditum, he was VP of Corporate Development at Neumora ('23 IPO), where he helped build the company from ideation through its public market debut. Before Neumora, Evan was Head of Corporate Development at Vir Biotechnology, leading more than 15 transactions in three years, including the deals that secured Vir's first two clinical-stage programs.

Earlier in his career, Evan was a product manager at Genentech and a healthcare investment. He holds an MBA from The Wharton School and a Master's in Biotechnology from the University of Pennsylvania.